Trase Raises $107M Seed to Deploy AI Agents in Healthcare

Trase secures major seed round for healthcare AI automation

Trase, a Northern Virginia startup building AI agents for regulated industries, has closed a $107 million seed round led by health-focused investor ARCH Venture Partners. Existing investor Red Cell Partners also participated in the funding, which follows a $10.5 million pre-seed round announced when the company emerged from stealth last November.

The company develops AI agents designed to handle repetitive, compliance-heavy tasks in healthcare and other sectors where privacy and security requirements have historically slowed technology adoption. Its platform, Trase Origin, maintains both HIPAA and SOC2 compliance certifications.

Why it matters

Healthcare organizations face a persistent tension between operational efficiency and regulatory compliance. Trase's model addresses this by automating low-value administrative work without compromising security standards, potentially freeing clinical staff to focus on patient care. The company's performance-based pricing—charging only when operations become measurably more efficient—also shifts implementation risk away from healthcare systems already operating on thin margins.

Performance-based pricing model

Unlike traditional software vendors, Trase doesn't charge upfront fees for its services. Instead, according to cofounder and president Baskar Sridharan, customers are billed based on demonstrated operational improvements. The company measures efficiency gains through metrics including hours saved, creating a direct link between the technology's value and its cost.

Cofounder and CEO Grant Verstandig said the approach aims to redirect highly trained professionals toward more complex work. "Agents are handling the onerous, immutable tasks that bog down highly trained individuals," Verstandig stated. "Shifting that valuable mental capacity to higher-acuity work will help make the most important systems in the United States cheaper, faster and better for every American."

Duke Health deployment shows results

The startup has been validating its technology through a partnership with Duke University Health System. Within Duke's cardiology department, Trase's AI agents now process more than 5,000 monthly faxes that previously required manual sorting and review. The health system has redirected the time saved toward direct patient care rather than reducing headcount.

"It liberated our team to focus on the work they actually trained for and enjoy doing," said Manesh Patel, Duke's chief of cardiology. "This work with Trase has shown us that the promise of AI in a clinical setting is real."

Expansion plans

Trase will use the seed funding to grow its go-to-market team and continue platform development. The company currently employs 55 people, primarily distributed between the Washington, D.C. region and Seattle.

These details were first reported by Technical.ly.